Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver | 16 | 2024 | 479 | 3.160 |
Why?
|
| Receptors, Steroid | 4 | 2017 | 36 | 2.060 |
Why?
|
| Obesity | 6 | 2024 | 1067 | 1.660 |
Why?
|
| Inflammation | 5 | 2024 | 618 | 1.510 |
Why?
|
| Hepatocytes | 4 | 2015 | 75 | 1.440 |
Why?
|
| Ethanol | 6 | 2017 | 192 | 1.430 |
Why?
|
| Retinoid X Receptor alpha | 5 | 2009 | 8 | 1.320 |
Why?
|
| Heme Oxygenase-1 | 1 | 2024 | 51 | 0.940 |
Why?
|
| Mice | 20 | 2024 | 5913 | 0.840 |
Why?
|
| Plants, Medicinal | 7 | 2004 | 68 | 0.840 |
Why?
|
| Liver Diseases, Alcoholic | 3 | 2015 | 7 | 0.810 |
Why?
|
| Oxidative Stress | 3 | 2024 | 938 | 0.720 |
Why?
|
| Methionine | 3 | 2008 | 30 | 0.710 |
Why?
|
| Mice, Knockout | 9 | 2024 | 933 | 0.710 |
Why?
|
| Fatty Liver, Alcoholic | 2 | 2017 | 2 | 0.700 |
Why?
|
| Animals | 26 | 2024 | 15081 | 0.670 |
Why?
|
| Choline Deficiency | 2 | 2008 | 4 | 0.640 |
Why?
|
| Mice, Inbred C57BL | 7 | 2024 | 1609 | 0.600 |
Why?
|
| Up-Regulation | 2 | 2017 | 513 | 0.570 |
Why?
|
| Plant Extracts | 5 | 2004 | 286 | 0.540 |
Why?
|
| Fatty Liver | 3 | 2020 | 64 | 0.530 |
Why?
|
| Dietary Fats | 2 | 2014 | 119 | 0.530 |
Why?
|
| Cytochrome P-450 CYP2E1 | 4 | 2024 | 16 | 0.520 |
Why?
|
| Tannins | 3 | 2004 | 4 | 0.510 |
Why?
|
| Hydrolyzable Tannins | 3 | 2004 | 16 | 0.500 |
Why?
|
| Balanophoraceae | 2 | 2004 | 2 | 0.490 |
Why?
|
| Male | 19 | 2024 | 20025 | 0.460 |
Why?
|
| Antioxidants | 5 | 2004 | 416 | 0.460 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2010 | 59 | 0.440 |
Why?
|
| Glucose | 1 | 2013 | 230 | 0.410 |
Why?
|
| Gene Expression Regulation | 5 | 2024 | 1015 | 0.390 |
Why?
|
| Enzyme Inhibitors | 2 | 2004 | 433 | 0.370 |
Why?
|
| Lipid Peroxidation | 3 | 2015 | 140 | 0.370 |
Why?
|
| Adipose Tissue, White | 2 | 2024 | 14 | 0.360 |
Why?
|
| Mixed Function Oxygenases | 3 | 2005 | 34 | 0.350 |
Why?
|
| Glutathione Transferase | 3 | 2005 | 88 | 0.350 |
Why?
|
| Cholestasis | 1 | 2009 | 9 | 0.340 |
Why?
|
| RNA, Messenger | 6 | 2017 | 1207 | 0.330 |
Why?
|
| Pyrimidines | 1 | 2009 | 118 | 0.310 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 2 | 2005 | 52 | 0.310 |
Why?
|
| Cytokines | 2 | 2009 | 602 | 0.290 |
Why?
|
| Female | 8 | 2024 | 20969 | 0.290 |
Why?
|
| Lipids | 1 | 2007 | 235 | 0.270 |
Why?
|
| Membrane Proteins | 2 | 2024 | 517 | 0.270 |
Why?
|
| Diet | 2 | 2008 | 801 | 0.240 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2024 | 16 | 0.240 |
Why?
|
| PPAR gamma | 1 | 2024 | 53 | 0.230 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2004 | 92 | 0.230 |
Why?
|
| Free Radical Scavengers | 3 | 2000 | 66 | 0.220 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 168 | 0.220 |
Why?
|
| Picrates | 2 | 2000 | 8 | 0.220 |
Why?
|
| Weight Gain | 1 | 2024 | 136 | 0.220 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 617 | 0.210 |
Why?
|
| Hepatomegaly | 2 | 2013 | 4 | 0.200 |
Why?
|
| Alcohol Dehydrogenase | 2 | 2015 | 10 | 0.200 |
Why?
|
| Liver Function Tests | 3 | 2008 | 18 | 0.200 |
Why?
|
| Atherosclerosis | 1 | 2023 | 134 | 0.200 |
Why?
|
| Microsomes, Liver | 4 | 2004 | 70 | 0.200 |
Why?
|
| RNA, Bacterial | 1 | 2021 | 33 | 0.200 |
Why?
|
| Glucose Tolerance Test | 1 | 2021 | 68 | 0.200 |
Why?
|
| Autophagy | 2 | 2020 | 116 | 0.190 |
Why?
|
| Proteins | 1 | 2024 | 369 | 0.190 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2021 | 171 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2004 | 1618 | 0.190 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 120 | 0.190 |
Why?
|
| Endothelial Cells | 1 | 2023 | 308 | 0.180 |
Why?
|
| Rats | 6 | 2004 | 3483 | 0.180 |
Why?
|
| Isoenzymes | 3 | 2006 | 161 | 0.170 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 147 | 0.170 |
Why?
|
| Bile Acids and Salts | 2 | 2009 | 33 | 0.160 |
Why?
|
| Aflatoxin B1 | 1 | 1998 | 4 | 0.160 |
Why?
|
| Receptors, Notch | 1 | 2018 | 33 | 0.160 |
Why?
|
| Serotonin | 1 | 2018 | 123 | 0.160 |
Why?
|
| Sex Factors | 1 | 2021 | 898 | 0.160 |
Why?
|
| Ghana | 3 | 2005 | 32 | 0.150 |
Why?
|
| Lipogenesis | 1 | 2017 | 18 | 0.150 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 145 | 0.150 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 190 | 0.150 |
Why?
|
| Gene Deletion | 1 | 2017 | 166 | 0.150 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2015 | 17 | 0.130 |
Why?
|
| Cyclin D1 | 1 | 2015 | 43 | 0.130 |
Why?
|
| Humans | 9 | 2020 | 37093 | 0.130 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 2 | 2008 | 15 | 0.130 |
Why?
|
| Estrogen Receptor alpha | 1 | 2015 | 111 | 0.120 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2014 | 24 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 623 | 0.120 |
Why?
|
| Glucokinase | 1 | 2013 | 3 | 0.120 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2013 | 6 | 0.120 |
Why?
|
| Hyperinsulinism | 1 | 2013 | 17 | 0.120 |
Why?
|
| Glucose Intolerance | 1 | 2014 | 42 | 0.120 |
Why?
|
| Ion Channels | 1 | 2014 | 71 | 0.120 |
Why?
|
| Medicine, African Traditional | 2 | 2004 | 6 | 0.120 |
Why?
|
| PPAR alpha | 1 | 2013 | 42 | 0.110 |
Why?
|
| Sex Characteristics | 1 | 2015 | 230 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2020 | 1198 | 0.110 |
Why?
|
| Species Specificity | 1 | 2013 | 245 | 0.110 |
Why?
|
| Mitochondrial Proteins | 1 | 2014 | 107 | 0.110 |
Why?
|
| Free Radicals | 3 | 2002 | 74 | 0.110 |
Why?
|
| Adipose Tissue | 1 | 2013 | 177 | 0.100 |
Why?
|
| Blood Glucose | 1 | 2014 | 353 | 0.100 |
Why?
|
| Injections, Intraperitoneal | 2 | 2004 | 60 | 0.100 |
Why?
|
| Lipid Metabolism | 2 | 2008 | 119 | 0.090 |
Why?
|
| Organ Size | 2 | 2008 | 157 | 0.090 |
Why?
|
| Alcohol Drinking | 1 | 2015 | 519 | 0.090 |
Why?
|
| Endocrine System | 1 | 2010 | 11 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2018 | 1908 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2004 | 1039 | 0.090 |
Why?
|
| Homeostasis | 2 | 2008 | 188 | 0.090 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2009 | 2 | 0.080 |
Why?
|
| Steroid 12-alpha-Hydroxylase | 1 | 2009 | 2 | 0.080 |
Why?
|
| Peroxisomes | 1 | 2009 | 4 | 0.080 |
Why?
|
| Aspartate Aminotransferases | 2 | 1999 | 19 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2023 | 269 | 0.080 |
Why?
|
| Alanine Transaminase | 2 | 1999 | 30 | 0.080 |
Why?
|
| Organic Anion Transporters, Sodium-Independent | 1 | 2008 | 1 | 0.080 |
Why?
|
| Body Weight | 2 | 2008 | 434 | 0.080 |
Why?
|
| Coloring Agents | 1 | 2008 | 51 | 0.080 |
Why?
|
| Food, Formulated | 1 | 2008 | 4 | 0.080 |
Why?
|
| Glutathione | 2 | 2008 | 179 | 0.080 |
Why?
|
| Liver Cirrhosis | 1 | 2008 | 52 | 0.080 |
Why?
|
| Hepatitis | 1 | 2008 | 9 | 0.080 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2008 | 48 | 0.080 |
Why?
|
| S-Adenosylmethionine | 1 | 2008 | 38 | 0.080 |
Why?
|
| Mice, Inbred DBA | 1 | 2007 | 71 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 116 | 0.080 |
Why?
|
| Fatty Acids | 1 | 2008 | 127 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2010 | 1371 | 0.080 |
Why?
|
| Choline | 1 | 2008 | 59 | 0.070 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2008 | 77 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2008 | 859 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 643 | 0.070 |
Why?
|
| Acetaminophen | 1 | 2005 | 27 | 0.070 |
Why?
|
| Genotype | 2 | 2005 | 730 | 0.070 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2005 | 28 | 0.060 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2004 | 83 | 0.060 |
Why?
|
| Gene Frequency | 1 | 2005 | 195 | 0.060 |
Why?
|
| Cytosol | 1 | 2004 | 93 | 0.060 |
Why?
|
| Gene Expression | 1 | 2007 | 674 | 0.060 |
Why?
|
| Lymphangiogenesis | 1 | 2023 | 4 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 191 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 448 | 0.060 |
Why?
|
| Thrombospondin 1 | 1 | 2023 | 23 | 0.060 |
Why?
|
| Bepridil | 2 | 2000 | 2 | 0.060 |
Why?
|
| Carbon Tetrachloride | 2 | 2000 | 7 | 0.050 |
Why?
|
| Biphenyl Compounds | 2 | 2000 | 53 | 0.050 |
Why?
|
| Edetic Acid | 1 | 2002 | 23 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 161 | 0.050 |
Why?
|
| Chelating Agents | 1 | 2002 | 57 | 0.050 |
Why?
|
| Molecular Conformation | 1 | 2002 | 152 | 0.050 |
Why?
|
| Phenobarbital | 1 | 2000 | 3 | 0.050 |
Why?
|
| Artemisia | 1 | 2000 | 4 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2004 | 358 | 0.040 |
Why?
|
| Aniline Hydroxylase | 1 | 1999 | 2 | 0.040 |
Why?
|
| Galactosamine | 1 | 1999 | 4 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2002 | 461 | 0.040 |
Why?
|
| Time Factors | 1 | 2004 | 1742 | 0.040 |
Why?
|
| Liver Diseases | 1 | 1999 | 33 | 0.040 |
Why?
|
| Receptor, Serotonin, 5-HT1B | 1 | 2018 | 2 | 0.040 |
Why?
|
| Sleep | 1 | 2000 | 152 | 0.040 |
Why?
|
| Transfection | 1 | 2020 | 523 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2018 | 51 | 0.040 |
Why?
|
| Rats, Inbred F344 | 1 | 1998 | 245 | 0.040 |
Why?
|
| Smoking | 1 | 2004 | 940 | 0.040 |
Why?
|
| Cell Survival | 1 | 2018 | 864 | 0.030 |
Why?
|
| Middle Aged | 2 | 2005 | 10129 | 0.030 |
Why?
|
| Aged | 1 | 2005 | 6741 | 0.030 |
Why?
|
| Adult | 2 | 2005 | 11712 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 2008 | 41 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 80 | 0.020 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2008 | 42 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2008 | 40 | 0.020 |
Why?
|
| Triglycerides | 1 | 2008 | 138 | 0.020 |
Why?
|
| Cholesterol | 1 | 2008 | 205 | 0.020 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2005 | 4 | 0.020 |
Why?
|
| Disease Progression | 1 | 2008 | 601 | 0.020 |
Why?
|
| Carcinoma, Small Cell | 1 | 2004 | 6 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 421 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2004 | 534 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2004 | 178 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 251 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2004 | 1130 | 0.010 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2000 | 37 | 0.010 |
Why?
|
| Africa | 1 | 2000 | 76 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2000 | 98 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2000 | 289 | 0.010 |
Why?
|
| Risk Factors | 1 | 2004 | 3562 | 0.010 |
Why?
|